Android app Apple app link

Agenus Gets $22M Mortgage, Plans Strategic Realignment To Focus On Colorectal Cancer Drug Development

By Yahoo! Finance   |   1 year ago
Agenus Gets $22M Mortgage, Plans Strategic Realignment To Focus On Colorectal Cancer Drug Development

Agenus secures a $22 million mortgage, boosting cash reserves for upcoming investments. The company focuses on developing cancer drug BOT/BAL for MSS colorectal cancer, reducing external expenditures by 60% to optimize cash burn for future growth.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.